Palmiges is a branded formulation containing palmitoylethanolamide (PEA), genistein, and daidzein. These ingredients are used in a formulation marketed for nutritional and clinical support associated with nerve-related discomfort and inflammatory pathways. The product should be used only according to its approved label and the advice of a qualified healthcare professional.
The standard Palmiges formulation is listed with 300 mg of palmitoylethanolamide, 50 mg of daidzein, and 4 mg of genistein per unit. Palmiges Plus has a different composition, including 600 mg of PEA. Confirm the exact variant, dosage form, and label before entering product data.
Palmitoylethanolamide is a naturally occurring fatty-acid amide studied for its role in biological pathways involved in inflammatory responses and pain signalling. In formulated products, it may be included as a micronized ingredient. The grade and quantity should be verified against the product label.
Genistein is a plant-derived isoflavone commonly associated with soy and other botanical sources. It is studied for its biological activity, including interactions with cellular signalling pathways. In Palmiges, it is combined with PEA and daidzein as part of the formulation.
Daidzein is another plant-derived isoflavone, commonly associated with soy. It is included in the Palmiges formulation alongside PEA and genistein. The exact amount should be confirmed for the selected product variant.
Published product information lists the standard Palmiges formulation as:
Palmiges Plus is a separate formulation listed with 600 mg of PEA, 50 mg of daidzein, and 4 mg of genistein. These compositions should not be interchanged when creating a product page.
Palmiges is marketed for support in conditions involving nerve-related discomfort. It is not appropriate to promise that it will cure or prevent neuropathy or other diseases. Individual suitability and expected benefits must be assessed by a qualified healthcare professional.
Inform your healthcare professional about existing medical conditions, allergies, pregnancy or breastfeeding, and other medicines or supplements being used. Follow the product label and professional advice rather than self-prescribing or changing the dose.
Store the product according to the instructions on its packaging. Protect it from excessive moisture, direct sunlight, and unsuitable temperatures. Keep it out of reach of children.
Product Name: Palmiges
Key Ingredients: Palmitoylethanolamide (PEA), Genistein, Daidzein
Standard Listed Composition: PEA 300 mg + Daidzein 50 mg + Genistein 4 mg
Dosage Form: Confirm from the current pack
Brand / Product Attribution: Verify the exact manufacturer and marketer on the label
| Parameter | Specification |
|---|---|
| Appearance | Capsule or tablet |
| Identification | Palmiges formulation |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Palmiges (PEA, Genistein & Daidzein) Manufacturer in India | Mediocon Inc. and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Palmiges (PEA, Genistein & Daidzein) Manufacturer in India | Mediocon Inc. is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing before release with a Certificate of Analysis.
Export Markets
Quality & Compliance